1 / 5

APAC Self-Monitoring Blood Glucose Devices Market to reach $4bn by 2024

Asia Pacific self-monitoring blood glucose devices market size was valued at USD 2.7 billion in 2017

madhurip3918
Télécharger la présentation

APAC Self-Monitoring Blood Glucose Devices Market to reach $4bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Self-Monitoring Blood Glucose Devices Market in APAC is projected to surpass $4bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Key Insights from Asia Pacific Self-Monitoring Blood Glucose Devices Market: • Graphical Research says, Asia Pacific Self-Monitoring Blood Glucose Devices Market to reach USD 4 billion by 2024 • Rising prevalence of obesity in highly populated countries such as India and China will be a major factor that will drive the self-monitoring blood glucose devices market during the forecast period. • Several efforts undertaken by government and other organizations to increase awareness pertaining to diabetes management will accelerate SMBG devices market growth. • Advancements in technology to develop novel glucose monitoring devices coupled with availability of portable, user-friendly and accurate SMBG devices will increase the adoption of such advanced devices. • Continuous glucose monitors segment is estimated to witness lucrative growth of 6.8% during the forecast period. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Continued... • Hospitals segment accounted for USD 1.3 billion in 2017 and is anticipated to show significant growth over the analysis timeframe. • China self-monitoring blood glucose devices market accounted for USD 743.3 million revenue in 2017 and is estimated to witness robust growth over the forecast period. • Increasing prevalence of diabetes as well as growing elderly population will augment industry growth over the analysis timeframe. • Some of the notable players operating in Asia Pacific self-monitoring blood glucose devices market include Abbott Laboratories, All Medicus, Arkray, B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health. • Market players are focusing on new product development, acquisitions and mergers to broaden product portfolio as well as widen company’s customer base. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Browse Full Market Research Report On Asia Pacific Self-Monitoring Blood Glucose Devices Market @ https://bit.ly/2R4WyUw Request for a Sample of this Research Report @ https://bit.ly/2OfN5vM ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related